US Patent Issued to GlaxoSmithKline Intellectual Property Development on Jan. 20 for "Crystalline forms of gepotidacin" (North Carolina, Pennsylvania, Texas Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,809, issued on Jan. 20, was assigned to GlaxoSmithKline Intellectual Property Development Ltd. (Stevenage, Great Britain).

"Crystalline forms of gepotidacin" was invented by Ricky Wayne Couch (Durham, N.C.), Wenning Dai (West Chester, Pa.), Senthil Davison (Raleigh, N.C.), Israil Pendrak (Collegeville, Pa.) and Glenn Robert Williams (Pearland, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are novel crystalline forms of gepotidacin and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof."

The patent was filed on April 27, 2021, under Application No. 17...